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answers. Consequently, EVAR may be an option for symptomatic
intact, but not for ruptured AAAs.
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Reply
The issues surrounding the role of endovascular aneurysm
repair (EVAR) in the management of ruptured abdominal aortic
aneurysms (AAAs) are complex. This meta-analysis set out to
examine the current published data. Statistical analysis of the
overall hospital length of stay was not affected by heterogeneity or
bias and showed an 8.6-day reduction in those patients treated
with EVAR relative to open surgery. We suspect that most sur-
geons, patients, and hospital managers would be very pleased with
this outcome.
Although we accept that there may be some potential publi-
cation bias that resulted in us finding a 37.6% reduction in mortal-
ity and a 4-day reduction in the intensive treatment unit with
EVAR, these findings would be supported by the overall improve-
ment in length of stay. It is very difficult to see how these data
could be interpreted in such a negative way for the authors of the
letter to state “EVAR may be an option for symptomatic intact, but
not for ruptured AAAs.”
Many people have called for more randomized controlled
trials in this area, and some have even tried to run them. We believe
that trying to find out whether open repair or EVAR is better for
ruptured AAAs is asking the wrong question. A trial such as this
would exclude two important groups—those not stable enough
for EVAR and those who are not potentially fit enough to survive
an open repair. Those in the latter group are not EVAR II type
patients because they have ruptured AAAs and their immediate life
expectancy is very different. The question that should be asked
about EVAR is “What happens to the overall mortality of all
patients admitted to our institution with ruptured AAAs if we
include EVAR in our armamentarium?”
Centers committed to offering the best treatment for patients
with ruptured AAAs should provide a service that can offer EVAR
on a 24-hour basis.
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Carotid endarterectomy under local anesthesia may be
the treatment of choice for symptomatic carotid
artery stenosis
Two recent meta-analyses comparing carotid endarterectomy
(CEA) with carotid artery stenting (CAS) for symptomatic carotid
artery stenosis showed that CEA is superior to CAS with respect to
30-day stroke/death rates.1,2 The first meta-analysis included
2985 patients of whom 2646 (89%) were symptomatic and showed
a significant 38% increase in the odds of any stroke or death 30
days after treatment (odds ratio, 1.38; 95% confidence interval
[CI], 1.04-1.83; P  .024).1 The second meta-analysis included
3580 patients and showed that although patients undergoing CAS
had a higher risk of 30 day-stroke/death compared with patients
undergoing CEA (risk ratio [RR], 1.30; 95% CI, 1.01-1.67; P 
.05), the 30-day risk of stroke was not significantly different
between patients who underwent CAS vs CEA (RR, 1.27; 95% CI,
0.96-1.69).2 However, a subgroup analysis of trials enrolling only
symptomatic patients showed a higher risk of both 30-day stroke/
death (RR, 1.63; 95% CI, 1.18-2.25; P  .05) and 30-day stroke
rates (RR, 1.62; 95% CI, 1.13-2.31; P  .05) in CAS patients.2
The conclusion reached was that “surgical treatment still remains
the gold standard for treatment of patients with symptomatic
carotid artery stenosis, who do not have an increased risk.”1
In most of the trials included in the two meta-analyses, CEA
was performed under general anesthesia.1,2 A parameter that may
produce even better results for CEA compared with CAS (eg, even
lower 30-day stroke rates) is the performance of CEA under local
instead of general anesthesia. The use of local anesthesia for CEA
gives the surgeon the opportunity to directly assess the neurologic
status of the patient during the procedure. Moreover, CEA can be
safely performed under local anesthesia, even in high-risk patients.
A retrospective study of 365 procedures showed that the
performance of 200 CEAs with local anesthesia compared with
165 under general anesthesia was associated with significantly
lower stroke rates (1% vs 7.3%, respectively; P  .05), operation
time (104.5  24 vs 122  36 minutes, respectively; P  .0001),
cross-clamping time (14.6  4 vs 18.2  5 minutes, respectively;
P  .0001) and intraoperative shunt usage (8% vs 30.3%, respec-
tively; P  .0001).3 In addition, application of local instead of
general anesthesia was associated with decreased length of hospi-
talization (2.4  1.1 vs 4.1  1.9 days, respectively; P  .0001)
and associated costs ($885.71 $78.57 vs $1007.14 $135.71,
respectively; P  .0001).3 The superiority of local compared with
general anesthesia for CEA was supported in other similar trials, as
well.4,5
A drawback of these studies3-5 is their retrospective nature. A
prospective, multicenter randomized study, the General Anaes-
thetic versus Local Anaesthetic for carotid surgery (GALA) trial,
will soon report its results from 3529 patients undergoing CEA
under local vs general anesthesia.6 In the future, a similar, prospec-
tive, multicenter randomized trial comparing CAS with CEA per-
formed under local anesthesia may lead to the conclusion that “the
gold standard for symptomatic carotid artery stenosis” is indeed
surgical treatment, performed however, under local anesthesia.
Kosmas I. Paraskevas, MD, FASA
Department of Vascular Surgery
“Red Cross” Hospital
Athens, Greece
Department of Clinical Biochemistry (Vascular Disease
Prevention Clinic)
Academic Department of Surgery
Royal Free Hospital
London, United Kingdom
JOURNAL OF VASCULAR SURGERY
July 2008256 Letters to the Editor
REFERENCES
1. Ringleb PA, Chatellier G, Hacke W, Favre JP, Bartoli JM, Eckstein HH,
et al. Safety of endovascular treatment of carotid artery stenosis compared
with surgical treatment. A meta-analysis. J Vasc Surg 2008;47:350-5.
2. Brahmanandam S, Ding EL, Conte MS, Belkin M, Nguyen LL. Clinical
results of carotid artery stenting compared with endarterectomy. J Vasc
Surg 2008;47:343-9.
3. Gurer O, Yapici F, Enc Y, Cinar B, Ketenci B, Ozler A. Local versus
general anesthesia for carotid endarterectomy: report of 329 cases. Vasc
Endovascular Surg 2003;37:171-7.
4. Kalko Y, Kafali E, Aydin U, Kafa U, Kosker T, Basaran M, et al. Surgery
of the carotid artery: local anaesthesia versus general anaesthesia. Acta
Chir Belg 2007;107:53-7.
5. Bowyer MW, Zierold D, Loftus JP, Egan JC, Inglis KJ, Halow KD.
Carotid endarterectomy: a comparison of regional versus general anes-
thesia in 500 operations. Ann Vasc Surg 2000;14:145-51.
6. GALA trial. http://www.dcn.ed.ac.uk/gala/. Accessed, Feb 13, 2008.
doi:10.1016/j.jvs.2008.02.036
Regarding “Bedside vena cava filter placement with
intravascular ultrasound: A simple, accurate, single
venous access method”
Jacobs et al1 present a single-puncture venous access method
for bedside inferior vena cava filter placement that takes advantage
of the relationship between the filter delivery catheter and the
corresponding sheath available on some commercially available
filter placement kits. The essential steps involve using intravascular
ultrasound (IVUS) to guide sheath placement to a level just below
the lowest most renal vein, advancement of the filter delivery catheter
to the premeasured distance aligning the tip of the filter with the end
of the sheath, and then withdrawing the sheath in a “pin-pull” fashion
to allow deployment of the filter at the infrarenal level.
We have adopted this exact single-puncture technique as well
for bedside filter delivery. However, a cautionary note should be
placed here that for the single-puncture technique described by the
authors to work, predetermined marks on the filter delivery cath-
eter that indicate when the filter is at the end of the sheath and
when the filter is out of the sheath are essential.
The authors evaluated eight different filters and concluded
that three were ideally suited for this technique: the Trapease and
Optease filters (Cordis Corp, Miami Lakes, Fla) and the Günter-
Tulip filter (Cook Inc, Bloomington, Ind). The described single-
puncture technique works well for these three filters because of the
device-specific marks placed in the manufacturing process that
allow the operator to understand the interaction of the sheath and
delivery system. The authors state that these five other filters “can
all be placed with the alternative IVUS-guided techniques” but do
not provide other technical details.
To adapt the single-puncture technique to other filter devices,
it is essential to understand the relationship between the filter
delivery catheter and sheath. Our previously published technique,
described in the Journal of Vascular Surgery “Technical Notes” in
2005,2 involves a single-puncture approach that is more relevant to
filter delivery systems such as the Greenfield Vena Cava Filter
(Boston Scientific Corp, Natick, Mass) that do not have corre-
sponding marks on the filter delivery catheter, a technique that has
also evolved in our experience since this original description. The
steps are similar to those described by the authors up to the point
of guiding the end of the sheath with IVUS to a level just below the
lowest most renal vein. The difference is that in the absence of
marks on the filter delivery catheter, the sheath is then pulled back
over the IVUS probe a distance equivalent to the length that the
filter delivery catheter extends beyond the sheath. For the Green-
field filter system, this distance is approximately 7 cm. When the
filter delivery catheter is loaded into the sheath, the tip of the filter
will precisely align with the lowest most renal vein upon deploy-
ment.
In short, these techniques are variations of the same concept
and reinforce the importance of understanding the device compo-
nent relationships in order to achieve intended technical accuracy
for filter delivery. As bedside filters techniques continue to evolve,
the techniques described by the authors and in our previous
published “Technical Notes” continue to highlight the feasibility
and safety of filter placement using IVUS.
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I appreciate the insightful comments of the readers above and
agree in their analysis that understanding the relationships of the
filter delivery catheter and the delivery sheath lengths is essential to
the accurate deployment of filters using the single-puncture tech-
nique we described. Their single puncture technique, as described
for the Greenfield filter system, is indeed essentially the same as the
technique described in our report. However, the need to know the
distance the filter extends beyond the end of the sheath, and adjusting
the placement of the sheath back to accommodate for that distance is
an incremental additional step not required with the filter systems that
have manufactured markings on the delivery catheter to indicate the
position of the filter relative to the delivery sheath.
I share the enthusiasm of the readers for intravascular
ultrasound-guided filter placement. Their adaptation of the
single-puncture technique to a wider variety of filter systems is
an important expansion of the options.
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Regarding “In-stent restenosis after carotid artery
stenting is asymptomatic because of low embolic
potential”
We read with interest the study by Lal et al1 evaluating the
patterns of in-stent restenosis (ISR) after carotid artery stenting
(CAS). They developed an ultrasound classification of ISR based
on the length and distribution of lesions and they showed that type
IV ISR (defined as a diffuse 10 mm proliferative, extending
outside the stent) and a history of diabetes are predictors of need of
target lesion revascularization. In addition, all patients with reste-
nosis were asymptomatic during follow-up apart from ultrasono-
graphic types I to IV. This observation is in accordance with
previous studies and may be related to the etiopathogenesis of
restenosis (in-stent neointimal hyperplasia).2
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